Most supplement manufacturers say they follow cGMP.
Very few can actually prove it.
If you are building a supplement brand, this is one of the most important realities you need to understand:
cGMP is not a certification.
The FDA does not approve manufacturers.
And “GMP compliant” is often just a marketing statement.
This misunderstanding is one of the biggest hidden risks in the industry—and it is costing brands in recalls, regulatory action, and lost retail opportunities.
What cGMP Actually Means (21 CFR Part 111)
cGMP—Current Good Manufacturing Practices—is defined under 21 CFR Part 111 for dietary supplements.
It governs:
- Manufacturing processes
- Quality control systems
- Testing and verification
- Documentation and recordkeeping
- Handling of deviations
The FDA enforces these requirements through inspections and regulatory action.
But here is the key point:
cGMP is a regulatory framework—not a certification.
The FDA does not certify or approve supplement manufacturers.
The Industry Problem: “GMP Certified”
You will see this everywhere:
“We are GMP certified.”
The real question is: certified by who?
Because it is not the FDA.
Most “GMP certifications” come from:
- Private auditing organizations
- Industry groups
- Internal or loosely defined standards
Some are credible. Many are inconsistent.
There is no single, unified certification system in supplements.
Why This Matters for Your Brand
Two manufacturers can both claim “GMP compliant” while operating at completely different levels.
If your manufacturer fails, the consequences fall on you:
- FDA warning letters
- Product recalls
- Retail rejection
- Legal exposure
- Loss of consumer trust
Your name is on the label. Your brand carries the risk.
What Real Compliance Looks Like
Real compliance is not a claim—it is a system.
It includes:
- Documented SOPs for all processes
- Full batch traceability
- Deviation and CAPA systems
- Supplier qualification and verification
- Continuous audit readiness
If these systems are not clearly defined, consistently followed, and independently verifiable—your exposure increases.
The Missing Piece: Standardization
The FDA enforces compliance—but it does not standardize how manufacturers demonstrate it.
This creates:
- Inconsistent quality across facilities
- Varying audit standards
- Confusion for brands evaluating partners
ANSI 455-2: A More Defined Benchmark
ANSI 455-2 introduces structure into supplement manufacturing evaluation.
It provides:
- Defined compliance expectations
- Consistent audit frameworks
- Third-party accountability
- Greater transparency
For brands, it offers something the industry has long lacked:
A clear way to distinguish real systems from marketing language.
How to Choose the Right Manufacturing Partner
Do not choose based on price or speed alone.
Evaluate based on:
- Depth of CFR 111 implementation
- Transparency of systems and documentation
- Third-party accountability and audit discipline
- Risk mitigation processes (deviations, CAPA, traceability)
- Ability to support retail and global expansion
If a manufacturer cannot clearly explain how they operate—you are not reducing risk, you are inheriting it.
Why Risk Mitigation Matters
In this industry:
- The FDA holds the brand accountable
- Retailers hold the brand accountable
- Consumers blame the brand
Not the manufacturer.
Strong compliance systems reduce:
- Regulatory risk
- Financial exposure
- Brand damage
The Organimed Approach
At Organimed, we focus on what can be proven—not what is claimed.
We help brands:
- Understand real compliance requirements
- Evaluate manufacturing partners objectively
- Build structured, scalable systems
- Align with credible standards like ANSI 455-2
- Prepare for retail and international markets
Compliance is not a statement. It is a system.
CTA
If your manufacturer cannot clearly demonstrate their systems, your brand is exposed.
👉 Book a Compliance & Manufacturing Strategy Call